Read + Share
Amedeo Smart
Independent Medical Education
Picetti D, Kim J, Zhu W, Sandborn WJ, et al. No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn's Disease Treated with Anti-metabolite Therapy. Dig Dis Sci 2022;67:3115-3123.PMID: 34797442
Email
LinkedIn
Facebook
Twitter
Privacy Policy